# Pegylated Interferon to Treat Chronic Hepatitis D

> **NCT00023322** · PHASE2 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 13 (actual)

## Conditions studied

- Hepatitis D

## Interventions

- **DRUG:** Peginterferon Alpha-2a

## Key facts

- **NCT ID:** NCT00023322
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2012-05
- **Final completion:** 2012-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2013-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00023322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00023322, "Pegylated Interferon to Treat Chronic Hepatitis D". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00023322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*